Infusion and Injection Coding Cheat Sheet 2025

These definitions are not semantic. Get them wrong in the clinical note and you've already chosen the wrong code, before coding ever begins.

Infusion is the administration of medicine directly into the bloodstream via needle or catheter, and it must exceed 15 minutes to qualify as an infusion for facility coding purposes. Per CMS A53778, that time threshold is the entire dividing line between infusion codes and push codes. Fifteen minutes is not a guideline. It's a wall.

IV Push (IVP or bolus) is an infusion of 15 minutes or fewer. Short administration time, different code family entirely.

IV Piggyback (IVPB) is a secondary IV bag hung alongside a pre-existing primary IV bag through the same access site. The distinction between piggyback and concurrent infusion matters for how you document and code the encounter, and clinicians who treat these terms as interchangeable create real problems for coders downstream.

Hydration is the administration of pre-packaged fluids or electrolytes only. Not drugs. Not saline used to keep a line open. Not free-flowing IV fluid running alongside a therapeutic infusion. Per Noridian JE Part B, the purpose must be fluid or electrolyte replacement, full stop. I have seen this definition violated in clinical notes more times than I can count, usually because someone documented "IV fluids" without specifying purpose, and the coder had to go back and query.

Injection is administration through needle and syringe, whether subcutaneous, intramuscular, intra-arterial, or intravenous.

Concurrent infusion means multiple drugs infusing simultaneously through the same vascular access site. Sequential infusion means drugs administered one after another through the same access site.

The clinical note's language must map to these definitions exactly. "Piggyback" documented as a concurrent infusion will support a different code than the same drug documented as sequential. The note drives the code. If the note is imprecise, the coder cannot fix it by assumption, and they shouldn't try.

The Service Hierarchy That Determines Which Code Is "Initial"

The hierarchy runs from highest to lowest priority, per CPT guidelines:

1. Chemotherapy infusions
2. Chemotherapy injections and pushes
3. Non-chemotherapy therapeutic, prophylactic, or diagnostic infusions
4. Non-chemotherapy therapeutic, prophylactic, or diagnostic injections and pushes
5. Hydration

Hydration is always secondary. It cannot be the initial code when any drug administration occurs in the same encounter. Infusions outrank pushes within the same tier. Pushes outrank injections.

Here is where I see the most confusion in practice: the initial code is not necessarily the first service administered. Chronological order of administration is irrelevant to code selection. The hierarchy governs, not the clock. This trips up experienced coders who are used to working through an encounter in the order things happened. That instinct is wrong here.

In a facility setting, the initial code follows the hierarchy above regardless of the order services were given. In a physician office setting, the initial code reflects the primary reason for the encounter, meaning the coder must identify the key clinical purpose of the visit and apply the hierarchy within that context.

One boundary worth stating explicitly: CPT codes 96360 through 96379 and 96401 through 96425 are reportable by providers for physician office services. They are not reported by providers for services performed in a hospital outpatient department or emergency department, per CMS NCCI Chapter XI, 2025.

Hydration Codes 96360–96361: Time Rules and Limits on Use

96360 covers initial hydration for 31 minutes to one hour. The infusion must reach at least 31 minutes before this code is billable. That minimum threshold is firm, not approximate.

96361 is the add-on code for each additional hour of hydration. The time threshold for a second unit requires 91 total minutes at minimum. Once the first hour is complete, another 31 minutes must be administered before 96361 can be reported.

These codes are not used when IV fluid runs to keep a line open before or after a therapeutic infusion, when saline or electrolytes run free-flowing during chemotherapy or other therapeutic infusion, or when the purpose of the fluid is drug delivery rather than fluid or electrolyte replacement.

96360 and 96361 are never reported by a physician in a facility setting. This is a straightforward rule that still generates billing errors with some regularity.

The most common mistake with hydration codes is billing hydration as the initial code when a therapeutic drug was also administered during the same encounter. The hierarchy mandates that the drug administration code is initial. Hydration becomes secondary, or it is not separately billable at all. Auditors find this error easily, because it is a rule with no ambiguity and the patterns are obvious in claims data.

Therapeutic and Diagnostic Infusion and Injection Codes 96365–96379

This code family covers non-chemotherapy drug administration. The codes you'll use most often:

• 96365: IV infusion, therapeutic, prophylactic, or diagnostic, initial, up to one hour
• 96366: Each additional hour (add-on to 96365)
• 96367: Additional sequential infusion, new substance or drug, up to one hour (add-on)
• 96368: Concurrent infusion (add-on; reported once per encounter regardless of how many drugs run concurrently)
• 96372: Subcutaneous or intramuscular injection, single drug
• 96374: IV push, single or initial substance or drug
• 96375: IV push, each additional sequential substance or drug (add-on)
• 96376: Each additional sequential IV push, same drug (add-on); used only when the same drug is re-administered and the second push occurs more than 30 minutes after the first

96365 does not apply to chemotherapy drugs, which go to 96413. It does not apply to plain IV hydration, which goes to 96360. And it does not apply to any IV push of 15 minutes or fewer, which goes to 96374.

The three push codes, 96374, 96375, and 96376, are not interchangeable, and I want to be direct about this because I have watched billers conflate them repeatedly. 96374 is the initial push. 96375 handles each subsequent push of a different drug. 96376 handles a repeat of the same drug, and only when the second administration occurs more than 30 minutes after the first. That 30-minute threshold is the operative distinction.

For the additional-hour add-on 96366: documentation must show at least one hour and 31 minutes of total infusion time before the add-on is billable. Exceeding 60 minutes alone is insufficient.

96372 for intramuscular and subcutaneous injections carries no time component. It is reported per drug administered, not per hour.

Chemotherapy Administration Codes 96401–96417 and What Qualifies as Chemotherapy

What qualifies as chemotherapy for coding purposes is broader than the clinical shorthand suggests. It includes antineoplastic drugs, non-radionuclide anti-neoplastic drugs, and anti-neoplastic agents. Certain monoclonal antibodies are classified by CMS as chemotherapy. Immunotherapy drugs classified by CMS as chemotherapy follow the same administration hierarchy as cytotoxic agents.

Per the CMS IOM update effective January 2, 2025, classification now depends on multiple factors, not drug name alone. Clinical documentation of administration intensity matters. This means you cannot look at a drug name on a superbill and assume the chemotherapy code applies. The clinical record must support the intensity threshold. Coders who have relied on drug name as a proxy for code selection are now carrying audit exposure they may not realize is there.

Key codes in this family:

• 96401: Subcutaneous or intramuscular, non-hormonal anti-neoplastic
• 96402: Subcutaneous or intramuscular, hormonal anti-neoplastic
• 96409: IV push, single or initial chemotherapy drug
• 96411: IV push, each additional chemotherapy drug (add-on)
• 96413: IV infusion, chemotherapy, initial, up to one hour
• 96415: Each additional hour (add-on to 96413)
• 96416: Initiation of prolonged chemotherapy infusion exceeding eight hours, requiring portable or implantable pump
• 96417: Each additional sequential chemotherapy infusion, different drug, up to one hour (add-on)
• 96420: Intra-arterial, push technique
• 96422: Intra-arterial infusion, up to one hour

The minimum time rule for 96413 is one of the more reliable audit triggers in this code set: the infusion must reach at least 16 minutes. If it concludes at 15 minutes or fewer, the correct code is 96409, the push code. The 96415 additional-hour threshold follows the same rule as 96366, requiring at least one hour and 31 minutes of total infusion time in the documentation before the add-on is billable.

When chemotherapy and non-chemotherapy drugs are administered in the same encounter, the chemotherapy code is initial. Non-chemotherapy infusions and injections are reported with sequential or concurrent add-on codes under the chemotherapy initial. The hierarchy is not negotiable here, and the documentation needs to reflect it.

The One-Initial-Service Rule and When a Second Initial Code Is Permitted

Per CMS NCCI Policy Manual Chapter XI, 2025: CPT codes 96360, 96365, 96374, 96409, and 96413 are designated initial service codes. Only one may be reported per patient encounter. This is the one-initial-service rule, and in my experience, it is the most frequently violated rule in infusion billing, often by people who believe they have a legitimate clinical reason to do otherwise.

The initial code is not the first drug given. It is the code at the top of the hierarchy among all services provided that day.

None of the following justify a second initial code: an IV line that requires a restart, an IV rate that cannot be achieved through one line, or accessing a different port of a multi-lumen catheter. The single documented exception is when the clinical protocol requires drug administration at two genuinely separate IV access sites simultaneously. Medical necessity must be explicitly documented in the clinical record, not inferred from the drug order.

If an infusion spans midnight into a new calendar date, the portion on the new date is reported as a new initial code, 96365, not as the add-on 96366. It is a new billing date, which makes it a new initial service.

When the separate-site exception applies, append Modifier 59 to the second initial code. Without it, Noridian will deny the second initial code. Modifier 59 signals that the service was distinct and performed at a separate site.

Reporting E/M Services on the Same Date as Infusion or Injection Administration

CPT codes 96360 through 96379 and 96401 through 96425 are valued to include the work of a 99211. That means 99211 is not separately reportable with these codes. Do not bill it.

A higher-level E/M, codes 99202 through 99215, is separately billable when the physician performs a significant, separately identifiable service beyond routine pre-treatment monitoring or infusion supervision. The documentation must show that the physician did something clinically meaningful that stands apart from managing the infusion itself. Vague attestation language does not meet that bar.

Modifier 25 is appended to the E/M code, not to the infusion code, to signal that the E/M is distinct. A different diagnosis is not required to support modifier 25, but the documentation must independently justify the E/M level selected.

For same-day chemotherapy encounters, the E/M is billable when the physician's note documents clinical decision-making or evaluation beyond what is inherent to drug administration monitoring. The documentation standard is the same as for any outpatient visit.

The most common audit exposure here is appending modifier 25 to every infusion encounter as a matter of habit, without documentation of a separately identifiable service. Payers recognize this pattern. They see it constantly, and they audit it precisely because the documentation so often fails to support the modifier when examined. If you are appending modifier 25 reflexively, your claims are a liability waiting to be reviewed.

Concurrent and Sequential Infusion Billing Rules and Documentation Requirements

Sequential infusion means a new substance or drug follows the initial service through the same IV access. Report it with:

• 96367: Sequential therapeutic infusion, new drug (add-on to 96365)
• 96417: Sequential chemotherapy infusion, new drug (add-on to 96413)
• 96375: Sequential IV push, new drug (add-on to 96374)

Concurrent infusion means two or more drugs infuse simultaneously through the same vascular access. Report it with 96368, an add-on code reported only once per encounter regardless of how many drugs are running concurrently. Once. Not once per drug.

Documentation must show actual time overlap to support concurrent billing. A note that two bags were running simultaneously is the minimum acceptable. Without it, payers default to sequential, and sequential pays differently. Sequential and concurrent are not interchangeable billing options that a coder selects based on preference. The clinical record determines which applies, and if the clinical record is silent, the coder's hands are tied.

For same-drug repeat push, 96376 is the correct code only when the same drug is re-pushed and the second administration occurs more than 30 minutes after the first. Within 30 minutes, the second push is not separately reportable.

Map an encounter by starting with the initial code based on the hierarchy, then assigning sequential add-ons in order of administration for different drugs, flagging any concurrent overlap with 96368, and verifying that no second initial code appears on the claim unless the separate-site exception is documented and modifier 59 is appended.

Quick-Reference Modifier Guide for Infusion and Injection Claims

| Modifier | When It Applies | What It Signals | |----------|----------------|-----------------| | 25 | On the E/M code when a significant, separately identifiable E/M service is performed on the same date as an infusion or injection | The E/M is distinct from the infusion service and independently documented | | 59 | On the second initial code when the separate-site exception applies | The service was performed at a distinct vascular access site; required by Noridian to prevent denial | | 76 | Repeat procedure by the same physician | Same procedure repeated on the same day; not a substitute for 96376 in push scenarios | | 77 | Repeat procedure by a different physician | Same procedure, different provider | | 91 | Repeat clinical diagnostic laboratory test on the same day | Not typically used in infusion coding; relevant when labs accompany treatment | | GY | Item or service statutorily excluded from Medicare coverage | Used when a non-covered service is billed for denial purposes, such as for secondary payer processing | | JW | Drug amount discarded | Required by many MACs when unused drug from a single-dose vial is wasted; documentation of waste must appear in the clinical record | | JZ | No drug discarded | Affirmative attestation that no waste occurred; required by CMS when JW does not apply for certain drugs |

A modifier describes a service. It does not create one. If the documentation does not support the modifier, appending it does not strengthen the claim; it flags the claim for closer scrutiny and gives an auditor a cleaner path to a finding.

Payer-specific policies, including MAC LCDs and commercial payer guidelines, layer on top of everything in this reference. NCCI sets the floor, not the ceiling. Know your payer's rules, because any given payer may be stricter than CMS on any of these points, and when they are, their policy is what governs payment.